Logo image of PTX.DE

PALANTIR TECHNOLOGIES INC-A (PTX.DE) Stock Fundamental Analysis

FRA:PTX - Deutsche Boerse Ag - US69608A1088 - Common Stock - Currency: EUR

117.02  -0.86 (-0.73%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PTX. PTX was compared to 100 industry peers in the Software industry. PTX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PTX is valued quite expensively, but it does show have an excellent growth rating. This makes PTX very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year PTX was profitable.
In the past year PTX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PTX reported negative net income in multiple years.
PTX had a positive operating cash flow in 4 of the past 5 years.
PTX.DE Yearly Net Income VS EBIT VS OCF VS FCFPTX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

Looking at the Return On Assets, with a value of 8.47%, PTX belongs to the top of the industry, outperforming 83.00% of the companies in the same industry.
PTX has a better Return On Equity (10.52%) than 67.00% of its industry peers.
With a decent Return On Invested Capital value of 4.95%, PTX is doing good in the industry, outperforming 61.00% of the companies in the same industry.
Industry RankSector Rank
ROA 8.47%
ROE 10.52%
ROIC 4.95%
ROA(3y)0.38%
ROA(5y)-11.69%
ROE(3y)0.24%
ROE(5y)-19.79%
ROIC(3y)N/A
ROIC(5y)N/A
PTX.DE Yearly ROA, ROE, ROICPTX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

PTX has a better Profit Margin (18.32%) than 85.00% of its industry peers.
Looking at the Operating Margin, with a value of 13.02%, PTX is in the better half of the industry, outperforming 71.00% of the companies in the same industry.
Looking at the Gross Margin, with a value of 80.01%, PTX is in the better half of the industry, outperforming 71.00% of the companies in the same industry.
PTX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.02%
PM (TTM) 18.32%
GM 80.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.96%
GM growth 5Y3.56%
PTX.DE Yearly Profit, Operating, Gross MarginsPTX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

PTX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PTX has been increased compared to 1 year ago.
PTX has more shares outstanding than it did 5 years ago.
PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PTX.DE Yearly Shares OutstandingPTX.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
PTX.DE Yearly Total Debt VS Total AssetsPTX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 149.39 indicates that PTX is not in any danger for bankruptcy at the moment.
PTX has a Altman-Z score of 149.39. This is amongst the best in the industry. PTX outperforms 99.00% of its industry peers.
PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 149.39
ROIC/WACC0.55
WACC8.93%
PTX.DE Yearly LT Debt VS Equity VS FCFPTX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

PTX has a Current Ratio of 6.49. This indicates that PTX is financially healthy and has no problem in meeting its short term obligations.
PTX's Current ratio of 6.49 is amongst the best of the industry. PTX outperforms 90.00% of its industry peers.
PTX has a Quick Ratio of 6.49. This indicates that PTX is financially healthy and has no problem in meeting its short term obligations.
PTX's Quick ratio of 6.49 is amongst the best of the industry. PTX outperforms 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.49
Quick Ratio 6.49
PTX.DE Yearly Current Assets VS Current LiabilitesPTX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

9

3. Growth

3.1 Past

PTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.29%, which is quite impressive.
The Earnings Per Share has been growing by 43.07% on average over the past years. This is a very strong growth
Looking at the last year, PTX shows a very strong growth in Revenue. The Revenue has grown by 33.45%.
The Revenue has been growing by 31.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)64.29%
EPS 3Y43.07%
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)33.45%
Revenue growth 3Y22.95%
Revenue growth 5Y31.01%
Sales Q2Q%39.34%

3.2 Future

Based on estimates for the next years, PTX will show a very strong growth in Earnings Per Share. The EPS will grow by 38.39% on average per year.
PTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.67% yearly.
EPS Next Y44.02%
EPS Next 2Y35.07%
EPS Next 3Y35.14%
EPS Next 5Y38.39%
Revenue Next Year38.76%
Revenue Next 2Y33.58%
Revenue Next 3Y33.25%
Revenue Next 5Y34.67%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PTX.DE Yearly Revenue VS EstimatesPTX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
PTX.DE Yearly EPS VS EstimatesPTX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 300.05, the valuation of PTX can be described as expensive.
PTX's Price/Earnings is on the same level as the industry average.
PTX is valuated expensively when we compare the Price/Earnings ratio to 27.15, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 183.10 indicates a quite expensive valuation of PTX.
Based on the Price/Forward Earnings ratio, PTX is valued a bit more expensive than 63.00% of the companies in the same industry.
PTX is valuated expensively when we compare the Price/Forward Earnings ratio to 21.60, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 300.05
Fwd PE 183.1
PTX.DE Price Earnings VS Forward Price EarningsPTX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PTX indicates a slightly more expensive valuation: PTX is more expensive than 67.00% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as PTX.
Industry RankSector Rank
P/FCF 245.16
EV/EBITDA 725.23
PTX.DE Per share dataPTX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PTX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of PTX may justify a higher PE ratio.
A more expensive valuation may be justified as PTX's earnings are expected to grow with 35.14% in the coming years.
PEG (NY)6.82
PEG (5Y)N/A
EPS Next 2Y35.07%
EPS Next 3Y35.14%

0

5. Dividend

5.1 Amount

PTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PALANTIR TECHNOLOGIES INC-A

FRA:PTX (6/30/2025, 5:29:46 PM)

117.02

-0.86 (-0.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners55.69%
Inst Owner ChangeN/A
Ins Owners3.6%
Ins Owner ChangeN/A
Market Cap276.16B
Analysts66
Price Target91.64 (-21.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.75%
Min EPS beat(2)-0.58%
Max EPS beat(2)24.07%
EPS beat(4)3
Avg EPS beat(4)10.13%
Min EPS beat(4)-0.58%
Max EPS beat(4)24.07%
EPS beat(8)6
Avg EPS beat(8)7.9%
EPS beat(12)8
Avg EPS beat(12)-3.18%
EPS beat(16)10
Avg EPS beat(16)-7.02%
Revenue beat(2)2
Avg Revenue beat(2)2.49%
Min Revenue beat(2)0.43%
Max Revenue beat(2)4.56%
Revenue beat(4)4
Avg Revenue beat(4)2.02%
Min Revenue beat(4)0.43%
Max Revenue beat(4)4.56%
Revenue beat(8)4
Avg Revenue beat(8)0.38%
Revenue beat(12)5
Avg Revenue beat(12)0.18%
Revenue beat(16)7
Avg Revenue beat(16)0.43%
PT rev (1m)8.24%
PT rev (3m)11.57%
EPS NQ rev (1m)0.84%
EPS NQ rev (3m)4.25%
EPS NY rev (1m)1.41%
EPS NY rev (3m)3.53%
Revenue NQ rev (1m)0.28%
Revenue NQ rev (3m)4.12%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)2.95%
Valuation
Industry RankSector Rank
PE 300.05
Fwd PE 183.1
P/S 103.76
P/FCF 245.16
P/OCF 242.19
P/B 59.59
P/tB 59.59
EV/EBITDA 725.23
EPS(TTM)0.39
EY0.33%
EPS(NY)0.64
Fwd EY0.55%
FCF(TTM)0.48
FCFY0.41%
OCF(TTM)0.48
OCFY0.41%
SpS1.13
BVpS1.96
TBVpS1.96
PEG (NY)6.82
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.47%
ROE 10.52%
ROCE 7.03%
ROIC 4.95%
ROICexc 84.28%
ROICexgc 84.28%
OM 13.02%
PM (TTM) 18.32%
GM 80.01%
FCFM 42.32%
ROA(3y)0.38%
ROA(5y)-11.69%
ROE(3y)0.24%
ROE(5y)-19.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.96%
GM growth 5Y3.56%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 54.26%
Cap/Sales 0.52%
Interest Coverage 250
Cash Conversion 306.55%
Profit Quality 231.02%
Current Ratio 6.49
Quick Ratio 6.49
Altman-Z 149.39
F-Score6
WACC8.93%
ROIC/WACC0.55
Cap/Depr(3y)87.68%
Cap/Depr(5y)87.2%
Cap/Sales(3y)1.07%
Cap/Sales(5y)1.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.29%
EPS 3Y43.07%
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y44.02%
EPS Next 2Y35.07%
EPS Next 3Y35.14%
EPS Next 5Y38.39%
Revenue 1Y (TTM)33.45%
Revenue growth 3Y22.95%
Revenue growth 5Y31.01%
Sales Q2Q%39.34%
Revenue Next Year38.76%
Revenue Next 2Y33.58%
Revenue Next 3Y33.25%
Revenue Next 5Y34.67%
EBIT growth 1Y106.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.88%
EBIT Next 3Y42.46%
EBIT Next 5Y13.24%
FCF growth 1Y280.96%
FCF growth 3Y52.59%
FCF growth 5YN/A
OCF growth 1Y255.28%
OCF growth 3Y51.19%
OCF growth 5YN/A